The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion

Molecular and Cellular Biology

Volumn 26, Issue 14, 2006, Pages 5205-5213

  Oxelmark, Ellinor ^a   Roth, Jennifer M ^a   Brooks, Peter C ^a   Braunstein, Steven E ^a   Schneider, Robert J ^a   Garabedian, Michael J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CHAPERONE; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; FIBRONECTIN; MYC PROTEIN; PROTEIN P23; PROTEIN PS2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1;

ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL ADHESION; CELL STRAIN MCF 7; CONTROLLED STUDY; EMBRYO; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY DNA SEQUENCE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BASE SEQUENCE; BREAST NEOPLASMS; CATHEPSIN D; CELL ADHESION; CELL LINE, TUMOR; DNA, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MOLECULAR CHAPERONES; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEINS;

EID: 33745821260     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00009-06     Document Type: Article

References (36)

1. Bagatell, R., O. Khan, G. Paine-Murrieta, C. W. Taylor, S. Akinaga, and L. Whitesell. 2001. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin. Cancer Res. 7:2076-2084.
2. Beliakoff, J., R. Bagatell, G. Paine-Murrieta, C. W. Taylor, A. E. Lykkesfeldt, and L. Whitesell. 2003. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors. Clin. Cancer Res. 9:4961-4971.
3. Boxer, L. M., and C. V. Dang. 2001. Translocations involving c-myc and c-myc function. Oncogene 20:5595-5610.
4. Burrows, F., H. Zhang, and A. Kamal. 2004. Hsp90 activation and cell cycle regulation. Cell Cycle 3:1530-1536.
5. Chiosis, G., M. Vilenchik, J. Kim, and D. Solit. 2004. Hsp90: the vulnerable chaperone. Drug Discov. Today 9:881-888.
6. Dabrosin, C., A. C. Johansson, and K. Ollinger. 2004. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor? Breast Cancer Res. Treat. 85:229-238.
7. DeFranco, D. B., and P. Csermely. 2000. Steroid receptor and molecular chaperone encounters in the nucleus. Sci. STKE 2000:PE1.
8. Dubik, D., and R. P. Shiu. 1992. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594.
9. Eustace, B. K., T. Sakurai, J. K. Stewart, D. Yimlamai, C. Unger, C. Zehetmeier, B. Lain, C. Torella, S. W. Henning, G. Beste, B. T. Scroggins, L. Neckers, L. L. Ilag, and D. G. Jay. 2004. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 6:507-514.
10. Felts, S. J., and D. O. Toft. 2003. p23, a simple protein with complex activities. Cell Stress Chaperones 8:108-113.
11. Fliss, A. E., S. Benzene, J. Rao, and A. J. Caplan. 2000. Control of estrogen receptor ligand binding by Hsp90. J. Steroid Biochem. Mol. Biol. 72:223-230.
12. Freeman, B. C., and K. R. Yamamoto. 2002. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296:2232-2235.
13. Graham, J. D., D. L. Bain, J. K. Richer, T. A. Jackson, L. Tung, and K. B. Horwitz. 2000. Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. Steroids 65:579-584.
14. Hall, J. M., D. P. McDonnell, and K. S. Korach. 2002. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16:469-486.
15. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
16. Ioachim, E., A. Charchanti, E. Briasoulis, V. Karavasilis, H. Tsanou, D. L. Arvanitis, N. J. Agnantis, and N. Pavlidis. 2002. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur. J. Cancer 38:2362-2370.
17. Isaacs, J. S., W. Xu, and L. Neckers. 2003. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213-217.
18. Jameel, A., R. A. Skilton, T. A. Campbell, S. K. Chander, R. C. Coombes, and Y. A. Luqmani. 1992. Clinical and biological significance of HSP89 alpha in human breast cancer. Int. J. Cancer 50:409-415.
19. Jordan, V. C. 1999. Estrogen receptor as a target for the prevention of breast cancer. J. Lab. Clin. Med. 133:408-414.
20. Kamal, A., L. Thao, J. Sensintaffar, L. Zhang, M. F. Boehm, L. C. Fritz, and F. J. Burrows. 2003. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425:407-410.
21. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J. L. Port, N. Altorki, E. R. Port, D. Ruggero, S. V. Shmelkov, K. K. Jensen, S. Rafli, and D. Lyden. 2005. VEGFR1-positive hematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827.
22. Knoblauch, R., and M. J. Garabedian. 1999. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol. Cell. Biol. 19:3748-3759.
23. Krebs, J., P. Saremaslani, and R. Caduff. 2002. ALG-2: a Ca2+-binding modulator protein involved in cell proliferation and in cell death. Biochim. Biophys. Acta 1600:68-73.
24. Kushner, P. J., D. A. Agard, G. L. Greene, T. S. Scanlan, A. K. Shiau, R. M. Uht, and P. Webb. 2000. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74:311-317.
25. McLaughlin, S. H., F. Sobott, Z. P. Yao, W. Zhang, P. R. Nielsen, J. G. Grossmann, E. D. Laue, C. V. Robinson, and S. E. Jackson. 2006. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J. Mol. Biol. 356:746-758.
26. Mileo, A. M., M. Fanuele, F. Battaglia, G. Scambia, P. Benedetti-Panici, S. Mancuso, and U. Ferrini. 1990. Selective overexpression of mRNA coding for 90 kDa stress-protein in human ovarian cancer. Anticancer Res. 10:903-906.
27. Mollerup, J., T. N. Krogh, P. F. Nielsen, and M. W. Berchtold. 2003. Properties of the co-chaperone protein p23 erroneously attributed to ALG-2 (apoptosis-linked gene 2). FEBS Lett. 555:478-482.
28. Oxelmark, E., R. Knoblauch, S. Arnal, L. F. Su, M. Schapira, and M. J. Garabedian. 2003. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. J. Biol. Chem. 278:36547-36555.
29. Platet, N., S. Cunat, D. Chalbos, H. Rachefort, and M. Garcia. 2000. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol. Endocrinol. 14:999-1009.
30. Prest, S. J., F. E. May, and B. R. Westley. 2002. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J. 16:592-594.
31. Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
32. Stavreva, D. A., W. G. Muller, G. L. Hager, C. L. Smith, and J. G. McNally. 2004. Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol. Cell. Biol. 24:2682-2697.
33. Su, L. F., R. Knoblauch, and M. J. Garabedian. 2001. Rho GTPases as modulators of the estrogen receptor transcriptional response. J. Biol. Chem. 276:3231-3237.
34. Trikha, M., Y. A. De Clerck, and F. S. Markland. 1994. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res. 54:4993-4998.
35. Watson, P. H., R. T. Ron, and R. P. Shiu. 1991. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51:3996-4000.
36. Workman, P. 2003. Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmaco-kinetics and pharmacodynamics. Mol. Cancer Ther. 2:131-138.